BioLineRx gets US patent covering use of BL-8040 in immunotherapy
The patent includes claims to protect the use of a clinical-stage drug candidate BL-8040's composition for improving immune responses to…
The patent includes claims to protect the use of a clinical-stage drug candidate BL-8040's composition for improving immune responses to…
Dihon's OTC product portfolio includes Kang Wang for the treatment of dandruff and other scalp disorders and Pi Kang Wang,…